Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow evaluation in pediatric patients.

Fiona E Craig1

  • 1Division of Hematopathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. craigfe@msx.upmc.edu

Seminars in Diagnostic Pathology
|October 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Flow cytometric detection of clonal T-cell populations in CAR T-cell therapy related enteropathy.

Leukemia & lymphoma·2026
Same author

Multi-modal analysis reveals tumor and immune features distinguishing EBV-positive and EBV-negative post-transplant lymphoproliferative disorders.

Cell reports. Medicine·2024
Same author

Rapid Expansion of a Teledermatology Web Application for Digital Dermatology Assessment Necessitated by the COVID-19 Pandemic: Retrospective Evaluation.

JMIR dermatology·2023
Same author

Evaluation of Novel Targets, Including CC-Chemokine Receptor 4, in Adult T-Cell Acute Lymphoblastic Leukemia/Lymphoma: A Mayo Clinic Clinical and Pathologic Study.

Archives of pathology & laboratory medicine·2023
Same author

Rare Multisystem Histiocytic Sarcoma on <sup>18</sup>F-FDG PET/CT.

Journal of nuclear medicine technology·2021
Same author

Primary cutaneous CD4<sup>+</sup> small/medium T-cell lymphoproliferative disorder: Diagnosis and management.

Journal of the American Academy of Dermatology·2021
Same journal

Update on the molecular pathology of the distinctive giant cell, fibro-osseous and bone forming lesions of the jaws.

Seminars in diagnostic pathology·2026
Same journal

Update on the molecular pathology and classification of odontogenic cysts and tumours.

Seminars in diagnostic pathology·2026
Same journal

MDM2 gene amplification in surgical pathology: biology, diagnostic utility, and clinical relevance in the modern era.

Seminars in diagnostic pathology·2026
Same journal

When three negatives equal a positive: Molecular updates of triple-negative breast carcinomas with favorable prognoses.

Seminars in diagnostic pathology·2026
Same journal

Old school, new insight: Revisiting histomorphology in the modern era of prostate cancer risk stratification.

Seminars in diagnostic pathology·2026
Same journal

Recent advances in genetic predisposition to primary testicular tumors.

Seminars in diagnostic pathology·2026
See all related articles

Evaluating pediatric bone marrow requires specialized knowledge distinct from adult specimens. This review covers key pediatric hematologic malignancies, highlighting diagnostic challenges and approaches for accurate prognostication and classification.

Area of Science:

  • Hematology
  • Pediatric Pathology
  • Oncology

Background:

  • Pediatric bone marrow evaluation presents unique challenges for pathologists accustomed to adult specimens.
  • Accurate diagnosis of pediatric hematologic malignancies requires a specialized approach.

Purpose of the Study:

  • To review key pediatric hematologic malignancies.
  • To illustrate the distinct approach needed for pediatric bone marrow evaluation.
  • To highlight potential diagnostic pitfalls in pediatric hematologic disorders.

Main Methods:

  • Review of selected pediatric hematologic malignancies.
  • Discussion of ancillary studies for prognostication.
  • Analysis of classification systems for pediatric leukemias and myelodysplastic syndromes.

Related Experiment Videos

Main Results:

  • Specific features of pediatric acute lymphoblastic leukemia, acute myeloid leukemia, congenital acute leukemia, myelodysplastic syndromes, and juvenile myelomonocytic leukemia are discussed.
  • Distinction between congenital acute leukemia and Down syndrome-associated transient myeloproliferative disorder is clarified.
  • Juvenile myelomonocytic leukemia is presented as a distinct childhood entity.

Conclusions:

  • A tailored approach is essential for accurate pediatric bone marrow evaluation.
  • Understanding specific features and diagnostic pitfalls is crucial for pediatric hematologic malignancy diagnosis.
  • This review provides a framework for pathologists evaluating pediatric bone marrow specimens.